Biotech Values

[mouton29]

You refer to arm C as the “masking arm” but Ocular in the presentation (slides 54 and 61) calls it the “comparator arm”. I think you are right, the trial is comparing Axpaxli every 6 months to Eyelea every 8 weeks, so I don’t see why they call C the comparator. I assume the purpose of C is to mask the Axpaxli arm; patients and investigators won’t know whether the injection every 6 months is Eyelea or Axpaxli. But I don’t think they said that explicitly unless there was something in the Q&A that I missed.